Published in
American Association for the Advancement of Science, Science Translational Medicine, 601(13), 2021
DOI: 10.1126/scitranslmed.abe9887
Links
Tools
Pan-caspase inhibition as a potential host-directed immunotherapy against MRSA and other bacterial skin infections
Journal article published in 2021 by
Martin P. Alphonse 
,
Jessica H. Rubens ,
Roger V. Ortines ,
Nicholas A. Orlando ,
Aman M. Patel ,
Dustin Dikeman,
Yu Wang ,
Ivan Vuong ,
Daniel P. Joyce,
Jeffrey Zhang,
Mohammed Mumtaz ,
Haiyun Liu ,
Qi Liu,
Christine Youn ,
Garrett J. Patrick
and other authors.
,
Jessica H. Rubens ,
Roger V. Ortines ,
Nicholas A. Orlando ,
Aman M. Patel ,
Dustin Dikeman,
Yu Wang ,
Ivan Vuong ,
Daniel P. Joyce,
Jeffrey Zhang,
Mohammed Mumtaz ,
Haiyun Liu ,
Qi Liu,
Christine Youn ,
Garrett J. Patrick
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
A pan-caspase inhibitor, Q-VD-OPH, has therapeutic efficacy against preclinical methicillin-resistantStaphylococcus aureusskin infection.